{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:52:58Z","timestamp":1791874378640,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Extraintestinal manifestations (EIMs) in inflammatory bowel disease (IBD) may be a frequent complication to an underlying abnormal immune response. This study investigated the occurrence of EIMs in Crohn disease (CD) and ulcerative colitis (UC) patients using population-based data in Denmark from 2003 to 2016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this national registry-based study, incident CD and UC patients between 2003 and 2015 were matched on age and gender with non-IBD controls and followed until 2016. The selected EIMs for this study included 51 different diagnoses divided into biological systems of diseases, which were tested for differences in the timing and occurrence of EIMs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study cohort included 10,302 patients with CD and 22,144 patients with UC. The highest risk of patients experiencing EIM\/comorbidities for the first time before their IBD diagnosis was in the skin and intestinal tract systems. For CD, the odds ratio of having an EIM before or after IBD diagnosis, as compared with controls, was significant in the skin, intestinal tract, hepatopancreatobiliary, musculoskeletal, ocular, renal, and respiratory systems. For UC, the risks were similar before and after UC diagnosis, apart from the nervous system where the odds ratio was significantly higher before the diagnosis of UC, and significantly lower after diagnosis for diseases in the ocular system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>EIMs in CD and UC patients may also precede their IBD diagnosis. These findings may indicate a significant diagnostic delay of CD and UC, and the occurrence of known EIMs should prompt physicians to look for patients possibly having underlying IBD.<\/jats:p><\/jats:sec>","DOI":"10.1093\/crocol\/otaa070","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T19:27:01Z","timestamp":1597346821000},"source":"Crossref","is-referenced-by-count":18,"title":["Extraintestinal Manifestations and Other Comorbidities in Ulcerative Colitis and Crohn Disease: A Danish Nationwide Registry Study 2003\u20132016"],"prefix":"10.1093","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-0536","authenticated-orcid":false,"given":"Kasper","family":"Vadstrup","sequence":"first","affiliation":[{"name":"Janssen Immunology, Janssen-Cilag , Birker\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alulis","sequence":"additional","affiliation":[{"name":"Janssen Immunology, Janssen-Cilag , Birker\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Borsi","sequence":"additional","affiliation":[{"name":"Janssen Immunology, Janssen-Cilag , High Wycombe, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Rikke","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Janssen Immunology, Janssen-Cilag , Birker\u00f8d, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnete","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Market Access and Health Economy, Incentive , Holte, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Munkholm","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, North Zealand University Hospital, Capital Region , Frederikssund, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Qvist","sequence":"additional","affiliation":[{"name":"Surgical Department A and IBD Care, Odense University Hospital , Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11894-001-0068-6","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"3","author":"Bernstein","year":"2001","journal-title":"Curr Gastroenterol Rep."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0025-7125(16)30585-5","article-title":"Extraintestinal and systemic manifestations of inflammatory bowel disease","volume":"74","author":"Rankin","year":"1990","journal-title":"Med Clin North Am."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0889-8553(01)00019-X","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"31","author":"Su","year":"2002","journal-title":"Gastroenterol Clin North Am."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/j.cgh.2019.03.040","article-title":"Incidence of immune-mediated inflammatory diseases among patients with inflammatory bowel diseases in Denmark","volume":"17","author":"Burisch","year":"2019","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","article-title":"Extraintestinal manifestations in inflammatory bowel disease\u2014epidemiology, genetics, and pathogenesis","volume":"13","author":"Greuter","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MPG.0000000000001455","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease: prevalence, presentation, and anti-TNF treatment","volume":"65","author":"Greuter","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40","author":"Ardizzone","year":"2008","journal-title":"Dig Liver Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish National Patient Register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health."},{"key":"2023030921354015200_","author":"World Health Organization","year":"2016"},{"key":"2023030921354015200_","author":"Statistics Denmark"},{"key":"2023030921354015200_","author":"Sundhedsdatastyrelsen"},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/ibd\/izz265","article-title":"Cost burden of Crohn\u2019s disease and ulcerative colitis in the 10-year period before diagnosis\u2014a Danish register-based study from 2003\u20132015","volume":"26","author":"Vadstrup","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.amjmed.2019.07.007","article-title":"Pulmonary manifestations of inflammatory bowel disease","volume":"133","author":"Massart","year":"2020","journal-title":"Am J Med."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1093\/rheumatology\/keaa117","article-title":"Pulmonary adverse events of small molecule JAK inhibitors in autoimmune disease: systematic review and meta-analysis","volume":"59","author":"Khoo","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ecco-jcc\/jjaa002","article-title":"Outcome of ileal pouch-anal anastomosis in patients with indeterminate colitis: a systematic review and meta-analysis","volume":"14","author":"Emile","year":"2020","journal-title":"J Crohns Colitis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/ibd\/izz227","article-title":"Inflammatory pouch conditions are common after ileal pouch anal anastomosis in ulcerative colitis patients","volume":"26","author":"Kayal","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ibd.20542","article-title":"Two distinct groups of colorectal cancer in inflammatory bowel disease","volume":"15","author":"Brackmann","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/j.gastro.2005.12.037","article-title":"Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota","volume":"130","author":"Jess","year":"2006","journal-title":"Gastroenterology."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation","volume":"12","author":"Kappelman","year":"2014","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ibd\/izy190","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: a nationwide Swedish cohort study","volume":"25","author":"Weimers","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","article-title":"Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: a Danish nationwide cohort study 1977\u20132014","volume":"68","author":"Villumsen","year":"2019","journal-title":"Gut."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ecco-jcc\/jjz065","article-title":"Systematic analysis of the impact of diagnostic delay on bowel damage in paediatric versus adult onset Crohn\u2019s disease","volume":"13","author":"Schoepfer","year":"2019","journal-title":"J Crohns Colitis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00508-019-1451-3","article-title":"Diagnostic delay in patients with inflammatory bowel disease in Austria","volume":"131","author":"Novacek","year":"2019","journal-title":"Wien Klin Wochenschr."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/ecco-jcc\/jjx041","article-title":"The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicentre study","volume":"11","author":"Cantoro","year":"2017","journal-title":"J Crohns Colitis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/MIB.0000000000001257","article-title":"Impact of diagnostic delay and associated factors on clinical outcomes in a U.S. inflammatory bowel disease cohort","volume":"23","author":"Nguyen","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","article-title":"Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis","volume":"159","author":"Torres","year":"2020","journal-title":"Gastroenterology."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1403494811399956","article-title":"Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving","volume":"39","author":"Thygesen","year":"2011","journal-title":"Scand J Public Health."},{"key":"2023030921354015200_","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/1403494811404277","article-title":"Register-based studies of healthcare costs","volume":"39","author":"Kruse","year":"2011","journal-title":"Scand J Public Health."}],"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otaa070\/33693505\/otaa070.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/2\/3\/otaa070\/49482741\/otaa070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article-pdf\/2\/3\/otaa070\/49482741\/otaa070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T18:52:29Z","timestamp":1696531949000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/article\/doi\/10.1093\/crocol\/otaa070\/5896668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/crocol\/otaa070","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,7,1]]},"article-number":"otaa070"}}